|
Coping During COVID-19: Establishing Optimal TD Treatment Strategies and Patient Access Plans |
Addiction professional, AANP, APA, CME, CNE, CPE |
Psychiatry |
On-Demand Webcast |
|
Coping During COVID-19: Telepsychiatry: Approaches and Adaptations for TD Assessment |
Addiction professional, AANP, APA, CME, CNE, CPE |
Psychiatry |
On-Demand Webcast |
|
Coping During COVID-19: Short-Term and Potential Long-Term Impacts on Patients with TD |
Addiction professional, AANP, APA, CME, CNE, CPE |
Psychiatry |
On-Demand Webcast |
|
Coping During COVID-19: Top 3 Challenges Associated with Delivering Health Care to Patients with or at Risk of Developing TD |
Addiction professional, AANP, APA, CME, CNE, CPE |
Psychiatry |
On-Demand Webcast |
|
Varicose Veins: Causes, Symptoms, Diagnosis, and Treatment of Chronic Venous Insufficiency |
CME, CNE |
Cardiology, Vascular |
On-Demand Webcast |
|
Navigating Complex Treatment Landscapes in Oncology: Developing Clinical Pathways in Prostate Cancer |
CME, CNE, CPE |
Oncology |
On-Demand Webcast |
|
Leveraging Clinical Pathways to Navigate an Expanding and Complex Treatment Landscape: Considerations for Metastatic Breast Cancer |
CME, CNE, CPE |
Oncology |
On-Demand Webcast |
|
Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape of Advanced NSCLC |
CME, CNE, CPE |
Oncology |
On-Demand Webcast |
|
The Benefits of Clinical Pathways in the Systemic Treatment of Bladder Cancer |
CME, CNE, CPE |
Oncology |
On-Demand Webcast |
|
BTK Inhibitors in Hematologic Oncology Pathways: Pathway-Guided Choices in the Treatment of CLL |
CME, CNE, CPE |
Oncology |
On-Demand Webcast |
|
Advances in Minimal Residual Disease Monitoring Technology |
AANP, CME, CNE, CPE |
Hematology, Oncology |
On-Demand Webcast |
|
Alzheimer's Disease: The Importance of Early Detection and Collaborative Care |
CME, CNE, CPE |
Family medicine, Internal medicine, Neurology, Psychiatry |
On-Demand Webcast |
